Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
114.54
-1.35 (-1.16%)
Jun 5, 2025, 3:00 PM CST

SHA:688266 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Operating Revenue
590.93531.53383.56301.67188.9927.6
Upgrade
Other Revenue
1.431.432.880.631.370.06
Upgrade
Revenue
592.35532.95386.44302.31190.3627.66
Upgrade
Revenue Growth (YoY)
53.23%37.91%27.83%58.81%588.19%-
Upgrade
Cost of Revenue
50.0437.7231.4227.537.10.57
Upgrade
Gross Profit
542.31495.23355.02274.78183.2627.09
Upgrade
Selling, General & Admin
363.87328.9264.84312.66216.9692.67
Upgrade
Research & Development
405.89388496.33497.73509.39314.2
Upgrade
Other Operating Expenses
-27.14-6.87-9.341.05-40.461.43
Upgrade
Operating Expenses
743.99712.25752.47812.83689.18408.3
Upgrade
Operating Income
-201.68-217.02-397.45-538.06-505.91-381.21
Upgrade
Interest Expense
-29.09-28.89-22.55-12.03-4.42-1.09
Upgrade
Interest & Investment Income
60.6961.2345.3132.6951.0445.78
Upgrade
Currency Exchange Gain (Loss)
-0.01-0.01-0.03-0.160.84.21
Upgrade
Other Non Operating Income (Expenses)
-1.35-1.74-2.88-3.48-8.39-0.53
Upgrade
EBT Excluding Unusual Items
-171.44-186.45-377.6-521.04-466.88-332.84
Upgrade
Gain (Loss) on Sale of Investments
1.443.928.732.631.744.84
Upgrade
Gain (Loss) on Sale of Assets
3.08--0.02--
Upgrade
Asset Writedown
---0.28-0.11-0.01-
Upgrade
Other Unusual Items
27.1827.4870.0730.55-23.17
Upgrade
Pretax Income
-139.74-155.05-299.08-487.95-465.15-304.83
Upgrade
Income Tax Expense
-4.76-4.75-3.95-2.45-3.165.84
Upgrade
Earnings From Continuing Operations
-134.98-150.3-295.13-485.51-461.99-310.68
Upgrade
Minority Interest in Earnings
8.3912.4716.5528.1810.99-8.55
Upgrade
Net Income
-126.59-137.83-278.58-457.33-451-319.23
Upgrade
Net Income to Common
-126.59-137.83-278.58-457.33-451-319.23
Upgrade
Shares Outstanding (Basic)
263265256239240235
Upgrade
Shares Outstanding (Diluted)
263265256239240235
Upgrade
Shares Change (YoY)
0.63%3.71%6.74%-0.19%2.20%30.61%
Upgrade
EPS (Basic)
-0.48-0.52-1.09-1.91-1.88-1.36
Upgrade
EPS (Diluted)
-0.48-0.52-1.09-1.91-1.88-1.36
Upgrade
Free Cash Flow
-156.34-57.49-295.35-458.97-525.36-401.54
Upgrade
Free Cash Flow Per Share
-0.59-0.22-1.16-1.92-2.19-1.71
Upgrade
Gross Margin
91.55%92.92%91.87%90.89%96.27%97.95%
Upgrade
Operating Margin
-34.05%-40.72%-102.85%-177.98%-265.77%-1378.15%
Upgrade
Profit Margin
-21.37%-25.86%-72.09%-151.28%-236.92%-1154.08%
Upgrade
Free Cash Flow Margin
-26.39%-10.79%-76.43%-151.82%-275.98%-1451.64%
Upgrade
EBITDA
-158.51-174.1-355.54-485.56-463.65-346.49
Upgrade
EBITDA Margin
-26.76%-32.67%-92.00%-160.62%-243.57%-
Upgrade
D&A For EBITDA
43.1742.9241.9152.542.2634.72
Upgrade
EBIT
-201.68-217.02-397.45-538.06-505.91-381.21
Upgrade
EBIT Margin
-34.05%-40.72%-102.85%-177.98%-265.77%-
Upgrade
Revenue as Reported
592.35532.95386.44302.31190.3627.66
Upgrade
Advertising Expenses
-0.391.3675.9533.81.31
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.